Research article
HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy
-
* Corresponding author: Jessica N McAlpine jessica.mcalpine@vch.ca
BMC Cancer 2009, 9:433 doi:10.1186/1471-2407-9-433
No comments have yet been made on this article.